ANTXR1 and small cell lung carcinoma: Despite the absence of any interactions between ANTXR1 glycans and SVV capsid, ANTXR1 deglycosylation was able to abrogate viral entry into the small-cell lung cancer cell line H446wt, highlighting its stringent effect on receptor function.